RAPT Therapeutics (RAPT) Short-term Investments: 2020-2024
Historic Short-term Investments for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $60.0 million.
- Therapeutics' Short-term Investments fell 54.07% to $60.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $60.0 million, marking a year-over-year decrease of 54.07%. This contributed to the annual value of $111.4 million for FY2023, which is 46.99% down from last year.
- Latest data reveals that Therapeutics reported Short-term Investments of $60.0 million as of Q3 2024, which was down 22.83% from $77.8 million recorded in Q2 2024.
- Therapeutics' 5-year Short-term Investments high stood at $210.1 million for Q4 2022, and its period low was $46.7 million during Q1 2020.
- In the last 3 years, Therapeutics' Short-term Investments had a median value of $140.6 million in 2022 and averaged $135.0 million.
- Per our database at Business Quant, Therapeutics' Short-term Investments soared by 91.27% in 2021 and then tumbled by 54.07% in 2024.
- Over the past 5 years, Therapeutics' Short-term Investments (Quarterly) stood at $86.6 million in 2020, then skyrocketed by 91.27% to $165.6 million in 2021, then climbed by 26.86% to $210.1 million in 2022, then plummeted by 46.99% to $111.4 million in 2023, then plummeted by 54.07% to $60.0 million in 2024.
- Its Short-term Investments stands at $60.0 million for Q3 2024, versus $77.8 million for Q2 2024 and $96.3 million for Q1 2024.